RANOLAZINE (RANOLAZINE) — NDC 73141-021 by A2A Integrated Pharmaceuticals
RANOLAZINE (RANOLAZINE) — NDC 73141-021 by A2A Integrated Pharmaceuticals is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: RANOLAZINE; Generic name: RANOLAZINE; Product NDC: 73141-021.
| Brand name | RANOLAZINE |
|---|---|
| Generic name | RANOLAZINE |
| Product NDC | 73141-021 |
| Labeler | A2A Integrated Pharmaceuticals |
| Dosage form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active ingredients | RANOLAZINE 500 mg/1 |
| Pharmacologic class | Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| Marketing category | ANDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →